Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

566
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
566
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

764
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
764

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6.

Journal of computer-aided molecular design·2026
Same author

Solvent Effects on the Photophysical Properties of Unexplored Imidazo[1,2‑<i>a</i>]pyridine Derivatives.

ACS omega·2026
Same author

Expanding the Palette of Molecular Fragments for Small Molecule De Novo Design Through Isosteric Swapping.

Journal of computational chemistry·2026
Same author

Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set.

Journal of chemical information and modeling·2025
Same author

Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2024
Same author

Fragment and torsion biasing algorithms for construction of small organic molecules in proteins using DOCK.

Journal of computational chemistry·2024
Same journal

DeepDPM: A Deep Learning Method for MoRFs Prediction Based on Wavelet Transform and Dynamic Convolutional Attention Mechanism.

Journal of chemical information and modeling·2026
Same journal

Graph-Based Generation and Reduction of Complex Chemical Reaction Networks.

Journal of chemical information and modeling·2026
Same journal

Modeling the Sensitivity of Large-Scale Virtual Screening to Scoring Function Accuracy, Artifacts, and Library Composition.

Journal of chemical information and modeling·2026
Same journal

Machine Learning-Driven Discovery of Indole/Oxoindole-Piperazine Scaffolds as Dual MAO-B/Sig-1R Ligands for Neurodegenerative Disorders.

Journal of chemical information and modeling·2026
Same journal

Mapping Evolution of Molecules across Biochemistry with Assembly Theory.

Journal of chemical information and modeling·2026
Same journal

Structural Proteomics-Based Deciphering of Hydrophobic Packing Fingerprints Informing Protein Thermostability in TIM Barrels.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

Updated: Jul 16, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

使用RDKit对DOCK6进行描述器驱动的de novo设计算法.

Guilherme Duarte Ramos Matos1,2, Steven Pak3, Robert C Rizzo1,4,5

  • 1Department of Applied Mathematics & Statistics, Stony Brook University, Stony Brook, New York 11794, United States.

Journal of chemical information and modeling
|September 12, 2023
PubMed
概括
此摘要是机器生成的。

在DOCK6中,一个新的描述器驱动的De Novo (D3N) 策略使用RDKit来设计药物线索. 这种方法通过计算化学信息学描述符来指导分子构造,使得针对药物发现的化学空间探索成为可能.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

318
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

71

相关实验视频

Last Updated: Jul 16, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

318
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

71

科学领域:

  • 计算化学是一种计算化学.
  • 药物发现 药物发现
  • 化学信息学 化学信息学

背景情况:

  • 通过计算来构建分子,新的设计对于发现新药的道至关重要.
  • 现有的方法可能缺乏精确控制分子构造过程中探索的化学空间.

研究的目的:

  • 在DOCK6软件中引入和验证一个描述器驱动的De Novo (D3N) 策略.
  • 通过在分子生长过程中计算用户定义的化学信息学描述符,实现量身定制的配体设计.

主要方法:

  • 将RDKit工具包集成到DOCK6中,用于飞行中的描述器计算.
  • 实施D3N策略,以指导基于指定的描述器范围的连接体生长.
  • 通过比较描述符计算,分析描述符分布和构建具有严格描述符约束的连接体的验证.

主要成果:

  • 确认了DOCK6/RDKit集成的稳定性.
  • 展示D3N在用户定义的化学空间内直接分子采样的能力.
  • 成功构建具有精确描述器配置文件的配体,引用临床相关化合物.

结论:

  • D3N策略增强了DOCK6用于有针对性的药物领先发现.
  • 随时描述器计算提供了一种强大的方法来设计具有所需属性的联体.
  • 这种整合有助于探索与毒品目标相关的特定化学空间.